These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 32113486)

  • 1. Efficacy of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea and tick infestations on dogs presented as veterinary patients in Europe.
    Becskei C; Fias D; Mahabir SP; Farkas R
    Parasit Vectors; 2020 Mar; 13(1):72. PubMed ID: 32113486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of a novel oral chewable combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea infestations in client-owned dogs in the USA.
    Kryda K; Mahabir SP; Inskeep T; Rugg J
    Parasit Vectors; 2020 Mar; 13(1):98. PubMed ID: 32113472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory studies evaluating the efficacy of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio™) for the treatment and control of flea infestations on dogs.
    Kryda K; Mahabir SP; Carter L; Everett WR; Young DR; Meyer L; Thys M; Chapin S; Holzmer SJ; Becskei C
    Parasit Vectors; 2020 Mar; 13(1):57. PubMed ID: 32113466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of combination products containing sarolaner, moxidectin and pyrantel (Simparica Trio™) or afoxolaner and milbemycin (NexGard Spectra
    Packianathan R; Hodge A; Bruellke N; Jackson C; Maeder S
    Parasit Vectors; 2020 Sep; 13(1):448. PubMed ID: 32891172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against induced infestations of five common tick species infesting dogs in the USA.
    Kryda K; Mahabir SP; Chapin S; Holzmer SJ; Bowersock L; Everett WR; Riner J; Carter L; Young D
    Parasit Vectors; 2020 Mar; 13(1):77. PubMed ID: 32113476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the speed of kill of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against induced infestations of Ixodes scapularis on dogs.
    Holzmer S; Kryda K; Mahabir SP; Everett W
    Parasit Vectors; 2020 Mar; 13(1):76. PubMed ID: 32113473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a novel chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against four common tick species infesting dogs in Europe.
    Becskei C; Liebenberg J; Thys M; Mahabir SP
    Parasit Vectors; 2020 Mar; 13(1):100. PubMed ID: 32113468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Field efficacy and safety of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against naturally acquired gastrointestinal nematode infections in dogs presented as veterinary patients in Europe and the USA.
    Becskei C; Kryda K; Fias D; Follis SL; Wozniakiewicz M; Mahabir SP; Farkas R
    Parasit Vectors; 2020 Mar; 13(1):70. PubMed ID: 32113470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Simparica Trio™, a novel chewable tablet containing sarolaner, moxidectin and pyrantel, against induced hookworm infections in dogs.
    Becskei C; Thys M; Kryda K; Meyer L; Martorell S; Geurden T; Dreesen L; Fernandes T; Mahabir SP
    Parasit Vectors; 2020 Mar; 13(1):99. PubMed ID: 32113471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a new oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against induced ascarid infections in dogs.
    Becskei C; Kryda K; Thys M; Holzmer S; Bowersock L; Fernandes T; Meyer L; Reinemeyer C; Mahabir SP
    Parasit Vectors; 2020 Mar; 13(1):71. PubMed ID: 32113482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™) in the treatment of naturally occurring flea and tick infestations in dogs presented as veterinary patients in Europe.
    Becskei C; De Bock F; Illambas J; Mahabir SP; Farkas R; Six RH
    Vet Parasitol; 2016 May; 222():49-55. PubMed ID: 26994516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of orally administered combination of moxidectin, sarolaner and pyrantel (Simparica Trio™) for the prevention of experimental Angiostrongylus vasorum infection in dogs.
    Becskei C; Thys M; Doherty P; Mahabir SP
    Parasit Vectors; 2020 Mar; 13(1):64. PubMed ID: 32113483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative speed of kill provided by lotilaner (Credelio™), sarolaner (Simparica Trio™), and afoxolaner (NexGard™) to control Amblyomma americanum infestations on dogs.
    Reif KE; Kollasch TM; Neilson JC; Herrin BH; Ryan WG; Bell MC; Beltz MS; Dryden MW; Jesudoss Chelladurai JRJ; Miller KR; Sutherland CJ
    Parasit Vectors; 2024 Jul; 17(1):313. PubMed ID: 39030610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of sarolaner (Simparica
    Packianathan R; Colgan S; Hodge A; Davis K; Six RH; Maeder S
    Parasit Vectors; 2017 Aug; 10(1):387. PubMed ID: 28814332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio
    Forster S; Wiseman S; Snyder DE
    Parasit Vectors; 2021 Jun; 14(1):299. PubMed ID: 34088338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative speed of kill of sarolaner (Simparica
    Packianathan R; Hodge A; Bruellke N; Davis K; Maeder S
    Parasit Vectors; 2017 Feb; 10(1):98. PubMed ID: 28222813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of a combination of selamectin plus sarolaner for the treatment and prevention of flea infestations and the treatment of ear mites in cats presented as veterinary patients in the United States.
    Vatta AF; Myers MR; Rugg JJ; Chapin S; Pullins A; King VL; Rugg D
    Vet Parasitol; 2019 Jun; 270 Suppl 1():S3-S11. PubMed ID: 30579753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative speed of kill of sarolaner (Simparica) and spinosad plus milbemycin oxime (Trifexis) against induced infestations of Ctenocephalides felis on dogs.
    Six RH; Everett WR; Myers MR; Mahabir SP
    Parasit Vectors; 2016 Feb; 9():93. PubMed ID: 26896448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a new spot-on formulation of selamectin plus sarolaner in the treatment of naturally occurring flea and tick infestations in cats presented as veterinary patients in Europe.
    Geurden T; Becskei C; Farkas R; Lin D; Rugg D
    Vet Parasitol; 2017 Apr; 238 Suppl 1():S12-S17. PubMed ID: 28395750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a new topical formulation of selamectin plus sarolaner for the control of fleas and ticks infesting cats in Japan.
    Yonetake W; Fujii T; Naito M; Hodge A; Maeder S; Rugg D
    Vet Parasitol; 2019 Jun; 270 Suppl 1():S12-S18. PubMed ID: 30914264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.